Skip to main content

Find Clinical Trials

Home
Conditions
Arthritis, Psoriatic

Clinical trial condition

Arthritis, Psoriatic

Explore clinical trials studying Arthritis, Psoriatic. Study availability and eligibility vary by location and protocol.

468 public trials 84 recruiting studies

Refine in advanced search Browse all conditions

Arthritis, Psoriatic trial results

Completed

A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis

NCT05195814

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations: Pfizer New York, United States

View Trial Details

Completed

Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease

NCT06568029

Conditions: Ankylosing Spondylitis, Ankylosis, Arthritis, +22 more
Locations: It is an observational study based on the The Swedish Rheumatology Quality Register Stockholm, Sweden

View Trial Details

Completed

A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic Arthritis

NCT03783026

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations: The Doctors of Saint John's Medical Group Santa Monica, California, United States

Inland Rheumatology Clinical Trials Inc Upland, California, United States

Malcom Randall VA Medical Center Gainesville, Florida, United States

Integral Rheumatology and Immunology Specialists Plantation, Florida, United States

View all 36 locations

View Trial Details

Completed

A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis

NCT03733925

Conditions: Ankylosis, Arthritis, Arthritis, Psoriatic, +13 more
Locations: ChanRe Rheumatology And Immunology Center And Research Bangalore, India

Apollo Hospitals Bhubaneswar, India

Chennai Meenakshi Multispeciality Hospital Chennai, India

Nizams Institute of Medical Sciences NIMS Hyderabad, India

View Trial Details

Completed

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)

NCT02319759

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations: Huntsville, Alabama, United States

Trumbull, Connecticut, United States

Clearwater, Florida, United States

Tampa, Florida, United States

View all 41 locations

View Trial Details

Completed

Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis

NCT00658827

Conditions: Ankylosis, Arthritis, Arthritis, Psoriatic, +24 more
Locations: Not specified

View Trial Details

Completed

A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab

NCT03336281

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations: Hôpital Edouard Herriot Lyon, France

View Trial Details

Completed

A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy

NCT03796858

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +10 more
Locations: CHU Saint Pierre BXL Brussels, Belgium

Reuma Clinic Genk, Belgium

Universitair Ziekenhuis Gent Ghent, Belgium

UZ Leuven Leuven, Belgium

View all 117 locations

View Trial Details

Completed

Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis

NCT05055934

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations: Huashan Hospital of the Shanghai FuDan University Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.

NCT03552276

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations: Site 25 Glendale, Arizona, United States

Site 16 Phoenix, Arizona, United States

Site 14 Denver, Colorado, United States

Site 27 Wichita, Kansas, United States

View all 66 locations

View Trial Details